Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-arginine supplementation effect on cardiovascular diseases in obesity
IRCT201501183236N6Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jan 2015
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of arginine in cardiac morbidity and obesity, sponsored by Shiraz University of Medical Sciences. Started Jan 2015; status: completed.
02
Drugs
arginine
03
Conditions
cardiac morbidityobesity
Beyond the preview
Go deeper on IRCT201501183236N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201501183236N6.